These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 24535143)
1. The expression of claudin 1 correlates with β-catenin and is a prognostic factor of poor outcome in gastric cancer. Huang J; Li J; Qu Y; Zhang J; Zhang L; Chen X; Liu B; Zhu Z Int J Oncol; 2014 Apr; 44(4):1293-301. PubMed ID: 24535143 [TBL] [Abstract][Full Text] [Related]
2. Claudin-1 enhances tumor proliferation and metastasis by regulating cell anoikis in gastric cancer. Huang J; Zhang L; He C; Qu Y; Li J; Zhang J; Du T; Chen X; Yu Y; Liu B; Zhu Z Oncotarget; 2015 Jan; 6(3):1652-65. PubMed ID: 25544763 [TBL] [Abstract][Full Text] [Related]
3. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218 [TBL] [Abstract][Full Text] [Related]
4. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients. Cui J; Xi H; Cai A; Bian S; Wei B; Chen L Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044 [TBL] [Abstract][Full Text] [Related]
5. Allograft inflammatory factor-1 is an independent prognostic indicator that regulates β-catenin in gastric cancer. Ye Y; Miao S; Lu R; Xia X; Chen Y; Zhang J; Wu X; He S; Qiang F; Zhou J Oncol Rep; 2014 Feb; 31(2):828-34. PubMed ID: 24337893 [TBL] [Abstract][Full Text] [Related]
6. The prognostic role of claudins -1 and -4 in oral squamous cell carcinoma. DE Vicente JC; Fernández-Valle Á; Vivanco-Allende B; Santamarta TR; Lequerica-Fernández P; Hernández-Vallejo G; Allonca-Campa E Anticancer Res; 2015 May; 35(5):2949-59. PubMed ID: 25964581 [TBL] [Abstract][Full Text] [Related]
7. Nuclear translocations of beta-catenin and TCF4 in gastric cancers correlate with lymph node metastasis but probably not with CD44 expression. Chen XY; Wang ZC; Li H; Cheng XX; Sun Y; Wang XW; Wu ML; Liu J Hum Pathol; 2005 Dec; 36(12):1294-301. PubMed ID: 16311123 [TBL] [Abstract][Full Text] [Related]
8. Slit2 expression and its correlation with subcellular localization of β-catenin in gastric cancer. Shi R; Liu W; Liu B; Xu Z; Chen L; Zhang Z Oncol Rep; 2013 Oct; 30(4):1883-9. PubMed ID: 23933755 [TBL] [Abstract][Full Text] [Related]
9. Short hairpin RNA targeting beta-catenin suppresses cell proliferation and induces apoptosis in human gastric carcinoma cells. Jiang H; Xia J; Kang J; Ding Y; Wu W Scand J Gastroenterol; 2009; 44(12):1452-62. PubMed ID: 19958059 [TBL] [Abstract][Full Text] [Related]
10. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Joo M; Lee HK; Kang YK Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426 [TBL] [Abstract][Full Text] [Related]
11. [Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival]. Zhou YN; Li M Ai Zheng; 2002 May; 21(5):536-40. PubMed ID: 12452049 [TBL] [Abstract][Full Text] [Related]
12. Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma. Che J; Yang Y; Xiao J; Zhao P; Yan B; Dong S; Cao B Tumour Biol; 2015 Aug; 36(8):6559-68. PubMed ID: 25820701 [TBL] [Abstract][Full Text] [Related]
13. In silico analysis and validation of the proliferative potential of CLDN1 expression in gastric cancer. Sathiya Pandi N; Manimuthu M; Asha GV; Gobic M; Rajendran S J Environ Pathol Toxicol Oncol; 2013; 32(4):343-60. PubMed ID: 24579786 [TBL] [Abstract][Full Text] [Related]
14. CHD8 is an independent prognostic indicator that regulates Wnt/β-catenin signaling and the cell cycle in gastric cancer. Sawada G; Ueo H; Matsumura T; Uchi R; Ishibashi M; Mima K; Kurashige J; Takahashi Y; Akiyoshi S; Sudo T; Sugimachi K; Doki Y; Mori M; Mimori K Oncol Rep; 2013 Sep; 30(3):1137-42. PubMed ID: 23835524 [TBL] [Abstract][Full Text] [Related]
15. Wnt pathway is involved in advanced gastric carcinoma. Zhang H; Xue Y Hepatogastroenterology; 2008; 55(84):1126-30. PubMed ID: 18705344 [TBL] [Abstract][Full Text] [Related]
16. Expression of CLDN1 in colorectal cancer: a novel marker for prognosis. Nakagawa S; Miyoshi N; Ishii H; Mimori K; Tanaka F; Sekimoto M; Doki Y; Mori M Int J Oncol; 2011 Oct; 39(4):791-6. PubMed ID: 21720707 [TBL] [Abstract][Full Text] [Related]
17. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141 [TBL] [Abstract][Full Text] [Related]
18. Loss of beta-catenin expression in metastatic gastric cancer. Ebert MP; Yu J; Hoffmann J; Rocco A; Röcken C; Kahmann S; Müller O; Korc M; Sung JJ; Malfertheiner P J Clin Oncol; 2003 May; 21(9):1708-14. PubMed ID: 12721245 [TBL] [Abstract][Full Text] [Related]
19. Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination. Cheng XX; Wang ZC; Chen XY; Sun Y; Kong QY; Liu J; Li H Cancer Lett; 2005 Jun; 223(2):339-47. PubMed ID: 15896469 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]